Scribe Therapeutics Rings the Opening Bell

Name: Scribe Therapeutics Rings the Opening Bell
Start: 2026-07-24T13:15:00
End: 2026-07-24T13:45:00
Location: 4 Times SquareNew York, NYUnited States

July 24, 2026 — 9:15 AM - 9:45 AM ET

Nasdaq MarketSite, 4 Times Square, New York

About This Event

Scribe Therapeutics (Nasdaq: SCTX) visits the Nasdaq MarketSite in Times Square. Scribe is a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention, with a focus on cardiovascular and metabolic diseases.

In honor of the occasion, Benjamin Oakes, PhD, Co-founder, President, and CEO, rings the Opening Bell.

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.